February is Heart Health Month, and a good time for people to pay attention to their cardiovascular health. Let us encourage women, especially, to speak up for their health – and that starts from the heart.
Why Should ?Women Look for MenaQ7® in Their Supplements
Clinical trials concerning women’s health are few and far between. The Lancet reports that cardiovascular disease among women is under studied, under diagnosed, and under-represented in clinical trials. Although this is concerning, we are proud that our MenaQ7® is clinically proven to support women’s cardiovascular health, and therefore represents a part of the solution.
Our groundbreaking 3-year study, published in Thrombosis and Haemostasis, showed post-menopausal women taking a daily nutritional dose of 180 mcg of MenaQ7®, not only inhibited age-related arterial stiffening but also promoted vascular elasticity.
Most recently, a poster and abstract of the findings from our 1-year follow-up study were presented at the European Society of Cardiology Congress. The authors confirmed that hormonal changes in women affect the vasculature and leaves post-menopausal women at higher risk. The study showed improved K2 status improves arterial stiffness and blood pressure in post-menopausal women.
Nutritional Needs and Supplementation are Part of the Answer
With the rising awareness of lifestyle’s impact on health, there is a growing trend toward proactive health choices. More consumers understand the connection between good heart health and overall well-being and are looking for guidance in ensuring more individual needs are met.
Taking a daily MenaQ7® supplement is an easy strategy proven to support heart health and should be a staple ingredient in any heart-smart formulation that aims to bring true benefits to its audience.
*Circulation. 2013;127(11):1254–63, e1–293